Replidyne
A biopharmaceutical company focused on the discovery and development of new antimicrobial drugs.
Launch date
Market cap
-
Enterprise valuation
AUD80—121m (Dealroom.co estimates Apr 2002.)
Louisville Kentucky (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
$13.0m | Series A | ||
| N/A | N/A | IPO | |
N/A | Acquisition | ||
| Total Funding | AUD20.1m | ||